Skip to main content
The Egyptian Journal of Bronchology
Download PDF
  • Original article
  • Open access
  • Published:

Serum uric acid as a biomarker for prediction of outcomes of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease

Egyptian Journal of Bronchology volume 8, pages 115–120 (2014)Cite this article

Abstract

Background

Serum uric acid, the final product of purine degradation, has been shown to be increased in the hypoxic state as well as in systemic inflammation including patients with chronic obstructive pulmonary disease (COPD). The aim of this study was to assess the possible role of serum uric acid as a biomarker for the prediction of outcome of patients hospitalized for acute exacerbation of COPD (AECOPD).

Patients and methods

Serum uric acid levels were measured in 115 eligible AECOPD patients on admission. The primary end-point was all-cause mortality at 30 days. The secondary outcomes included the length of hospital stay, need for noninvasive ventilation, or ICU admission within 30 days.

Results

Serum uric acid presented an area under the receiver operating characteristic curve of 0.721 (95% confidence interval: 0.63–0.80) for the prediction of 30-day mortality in patients with AECOPD, with a sensitivity of 0.82 and a specificity of 0.61 for the cutoff point greater than 6.9 mg/dl (P = 0.021). Also, patients with higher serum uric acid levels required longer hospitalization and more often required the use of noninvasive ventilation and ICU admission at 30 days. In addition, serum uric acid levels were higher in patients with more severe airflow limitation, patients with cardiovascular comorbidity, and among frequent exacerbators.

Conclusion

High serum uric acid levels on admission were associated with increased 30-day mortality in patients with AECOPD. The results of this work suggest a possible role for serum uric acid in the identification of COPD patients at an increased risk of adverse outcomes who may need early intensive management. Egypt J Broncho 2014 8:115–120

References

  1. Vestbo J, Hurd SS, Agustı´ AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347–365.

    Article  CAS  Google Scholar 

  2. Braghiroli A, Sacco C, Erbetta M, et al. Overnight urinary acid/creatinine ratio for detection of sleep hypoxemia: validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 1993; 148:173–178.

    Article  CAS  Google Scholar 

  3. Lewis JG, Gardner JE. The relation of serum uric acid to haemoglobin level in patients with cardiac and respiratory disease. J Clin Pathol 1960; 13:502–505.

    Article  CAS  Google Scholar 

  4. Saito H, Nishimura M, Shibuya E, et al. Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest 2002; 122:1686–1694.

    Article  CAS  Google Scholar 

  5. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003; 107:1991–1997.

    Article  Google Scholar 

  6. Shimizu Y, Nagaya N, Satoh T, et al. Serum acid uric level increases in proportion to the severity of pulmonary thromboembolism. Circ J 2002; 66:571–575.

    Article  Google Scholar 

  7. Nagaya N, Uematsu M, Satoh T, et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 1999; 160:487–492.

    Article  CAS  Google Scholar 

  8. Oya H, Nagaya N, Satoh T, et al. Haemodynamic correlates and prognostic significance of acid uric in adult patients with Eisenmenger syndrome. Heart 2000; 84:53–58.

    Article  CAS  Google Scholar 

  9. Kojima S, Sakamoto T, Ishihara M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction. The Japanese Acute Coronary Syndrome Study. Am J Cardiol 2005; 96:489–495

    Article  CAS  Google Scholar 

  10. Garcia-Pachon E, Padilla-Navas I, Shum C. Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease. Lung 2007; 185:21–24.

    Article  CAS  Google Scholar 

  11. Bartziokas K, Papaioannou AI, Loukides S, et al. Serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur Respir J 2014; 43:43–53.

    Article  CAS  Google Scholar 

  12. Lopez IH. Serum uric acid levels among patients with chronic obstructive pulmonary disease. Chest 2003; 124:168S.

    Article  Google Scholar 

  13. Elsayed NM, Nakashima JM, Poslethwait EM. Measurement of uric acid as a marker of oxygen tension in the lung. Arch Biochem Biophys 1993; 302:228–232.

    Article  CAS  Google Scholar 

  14. Mateos AF, Garcia PJ, Gomez FP, et al. Degradation of purine nucleotides in patients with chronic airflow obstruction. Med Clin (Barc) 1989; 92:328–330.

    Google Scholar 

  15. Pascual-Figal DA, Hurtado-Martınez JA, Redondo B, et al. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 2007; 9:518–524.

    Article  CAS  Google Scholar 

  16. Ruggiero C, Cherubini A, Miller E3rd, et al. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol 2007; 100:115–121.

    Article  CAS  Google Scholar 

  17. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370:797–799.

    Article  Google Scholar 

  18. Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:1065–1072.

    Article  CAS  Google Scholar 

  19. Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:250–255.

    Article  CAS  Google Scholar 

  20. Koutsokera A, Kiropoulos TS, Nikoulis DJ, et al. Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med 2009; 103:919–926.

    Article  Google Scholar 

  21. Stolz D, Christ-Crain M, Morgenthaler NG, et al. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest 2008; 134:263–272.

    Article  CAS  Google Scholar 

  22. Stolz D, Christ-Crain M, Morgenthaler NG, et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007; 131:1058–1067.

    Article  CAS  Google Scholar 

  23. Aida Y, Shibata Y, Osaka D, et al. The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study. Int J Med Sci 2011; 8:470–478.

    Article  CAS  Google Scholar 

  24. Sato N, Kurashima K, Ubukata M, et al. Prognostic significance of serum uric acid in patients with chronic obstructive pulmonary disease receiving home oxygen therapy [article in Japanese]. Nihon Kokyuki Gakkai Zasshi 2003; 41:74–80.

    PubMed  Google Scholar 

  25. Nicks ME, O’Brien MM, Bowler RP. Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers. COPD 2011; 8:264–269.

    Article  Google Scholar 

  26. Hunninghake DB. Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:44–49.

    Article  CAS  Google Scholar 

  27. Sin DD. Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107:1514–1519.

    Article  Google Scholar 

  28. So A, Thorens B. Uric acid transport and disease. J Clin Invest 2010; 120:1791–1799.

    Article  CAS  Google Scholar 

  29. Filippatos GS, Ahmed MI, Gladden JD, et al. Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J 2011; 32:712–720.

    Article  CAS  Google Scholar 

  30. Demartini FE. Hyperuricemia induced by drugs. Arthritis Rheum 1965; 8:823–829.

    Article  CAS  Google Scholar 

  31. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574–580.

    Article  CAS  Google Scholar 

  32. Holme I, Aastveit AH, Hammar N, et al. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009; 266:558–570.

    Article  CAS  Google Scholar 

  33. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359:1811–1821.

    Article  CAS  Google Scholar 

  34. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005; 52:283–289.

    Article  Google Scholar 

  35. Choi HK, Curhan G. Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2004; 51:1023–1029.

    Article  Google Scholar 

  36. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD 2006; 3:51–61.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chest, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Sameh Embarak MD, Ashraf E. Sileem & Maged Abdrabboh

  2. Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Ahmed Mokhtar

Authors
  1. Sameh Embarak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashraf E. Sileem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maged Abdrabboh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmed Mokhtar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sameh Embarak MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Embarak, S., Sileem, A.E., Abdrabboh, M. et al. Serum uric acid as a biomarker for prediction of outcomes of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. Egypt J Bronchol 8, 115–120 (2014). https://doi.org/10.4103/1687-8426.145703

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.145703

Keywords